UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 29, 2021 4:00 P.M.

Form:	S-4
CIK: 0001867096 Company Name: Xeris Biopharma Holdings, Inc. File Number: 333-257642